GlassScriptPhysician profile
Kevin M Luftman
NPI 1528326402
$2,235.44
in general payments reported to CMS, 2019-2025
23 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,314 · 2020: $51.26 · 2021: $74.23 · 2022: $33.38 · 2023: $399 · 2024: $86.02 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $742.54 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $1,323.44 | 2019-2023 | |
| Stryker Corporation | $274.98 | 2020-2023 | Aequalis Ascend Flex, Actishield Cf |
| Vantive US Healthcare LLC | $92.59 | 2025 | Renal - Acute |
| Csl Behring | $50.24 | 2019-2024 | Kcentra |
| Portola Pharmaceuticals, LLC | $48.22 | 2019 | |
| Alexion Pharmaceuticals, INC. | $40.25 | 2021-2022 | |
| Avita Medical Americas, LLC | $39.55 | 2024 | |
| Tela Bio, INC. | $38.39 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| W. L. Gore & Associates, INC. | $36.97 | 2025 | Gore Enform Preperitoneal Biomaterial |
| La Jolla Pharmaceutical Company | $32.28 | 2021-2022 | |
| Lifenet Health | $29.05 | 2025 | Theragenesis Wound Matrix |
| Urgo Medical North America, LLC | $27.46 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Haemonetics Corporation | $26.47 | 2024 | Teg6s Hemostasis System |
| Pacira Pharmaceuticals Incorporated | $22.62 | 2020 | |
| Access Pro Medical, LLC | $22.38 | 2025 | Matriderm |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $22.22 | 2019 | |
| Integra Lifesciences Corporation | $20.04 | 2021 | |
| Solventum Corporation | $16.30 | 2025 | V.A.C.Instill, Activ.A.C., Prevena |
| Atricure, INC. | $15.04 | 2021 | |
| Acell, INC. | $14.91 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $14.53 | 2025 | |
| Edwards Lifesciences Corporation | $14.44 | 2023 | Hemosphere |
| Brainscope Company, INC. | $13.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Luftman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.